Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vicki L. Sato currently holds 1,100,391 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vicki L. Sato has been a net seller of DNLI stock. They have purchased $0 and sold $17.9M worth of shares.
Vicki L. Sato's most recent insider trade was on Apr 1, 2026, when they sold 22,000 shares at $9.07 per share.
Vicki L. Sato serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 153 insider transactions totaling $17.9M over their tenure at the company.
Vicki L. Sato holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Vicki L. Sato has shown a selling trading pattern, with $0 in total purchases and $17.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Vicki L. Sato was on Aug 8, 2022, when they sold $542.6K worth of VIR shares. This transaction involved 17,915 shares at $30.29 per share.
Vicki L. Sato currently owns 1,100,391 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vicki L. Sato's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vicki L. Sato has 153 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Vicki L. Sato and 40,000+ other insiders.